Moderna
MRNA
#1308
Rank
โ‚ฌ14.52 B
Marketcap
37,18ย โ‚ฌ
Share price
-5.95%
Change (1 day)
-3.35%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚ฌ8.06 M-87.92%
2025โ‚ฌ66.81 M-57.25%
2024โ‚ฌ0.15 B15.08%
2023โ‚ฌ0.13 B-50.15%
2022โ‚ฌ0.27 B-85.7%
2021โ‚ฌ1.90 B158.2%
2020โ‚ฌ0.73 B369.18%
2019โ‚ฌ0.15 B1011.49%
2018โ‚ฌ14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
โ‚ฌ24.94 Mโ‚ฌ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ93.01 Mโ‚ฌ0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚ฌ36.21 Mโ‚ฌ0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
N/Aโ‚ฌ5.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ0.09 Mโ‚ฌ0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ9.93 Mโ‚ฌ38.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ3.87 Mโ‚ฌ10.57 M๐Ÿ‡บ๐Ÿ‡ธ USA